Migrevention is an Estonian digital health technology company and a medical device manufacturer. The company's slogan, "Fully digital headache clinic | Estonia’s first software based medical device manufacturer," encapsulates its innovative approach. Founded in 2020, Migrevention focuses on the Health Care industry with its headquarters based in Estonia.
Specializing in providing digital solutions for patients, specialists, and clinics to monitor, diagnose, and treat migraine and other primary headaches, Migrevention is at the forefront of creating innovative solutions in personal medicine. The company aims to transform the patient-specialist relationship through its cutting-edge technology.
Notably, Migrevention secured a €355.00K Pre Seed Round investment on 03 January 2022, with the investment coming from Dag Nurm. This investment underscores the confidence in Migrevention's potential and signifies a significant milestone in its growth and development.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Pre Seed Round | €355.00K | 1 | Dag Nurm | 03 Jan 2022 |
No recent news or press coverage available for Migrevention.